Research Priorities

 
News Articles for Research Priorities top ^
SAN RAFAEL, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that it has sold the Rare Pediatric Disease Priority Review Voucher (PRV) it obtained in February of this year.
Sign-up for BioMarin Sells Priority Review Voucher for $67.5 Million investment picks
TARRYTOWN, N.Y. and PARIS , July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Sanofi (EURONEXT: SAN and NYSE: SNY ) today announced that the Companies intend to use a U.S. Food and Drug Administration (FDA) rare pediatric disease priority review voucher in connection with the Biologics License Application (BLA) submission for alirocumab.
Sign-up for Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission investment picks
Ipsen N.A. , an affiliate of Ipsen (Euronext:IPN; ADR:IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline ® Depot ® 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options.
Sign-up for Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NETs1 in the US with Priority Review investment picks
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of its supplemental New Drug Application (sNDA) for Somatuline ® Depot ® 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). The FDA designates priority review status to drug candidates that have the potential to offer a significant improvement in treatment compared to currently approved options.
Sign-up for Ipsen Announces Acceptance of Filings for Somatuline® in the Treatment of GEP-NET1s in the US with Priority Review and in Europe investment picks
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and granted Priority Review for Avastin ® (bevacizumab) plus chemotherapy for the treatment of women with persistent, recurrent or metastatic cervical cancer.
Sign-up for FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer investment picks
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) and granted Priority Review for Avastin ® (bevacizumab) plus chemotherapy for the treatment of women with recurrent platinum-resistant ovarian cancer.
Sign-up for FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer investment picks
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bivalent recombinant LP2086 (rLP2086), the company’s vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 through 25 year olds.
Sign-up for Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine investment picks
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic ceftolozane/tazobactam with Priority Review.
Sign-up for Cubist Announces Acceptance of Ceftolozane/Tazobactam New Drug Application with Priority Review investment picks
2014/9/10
Cleaning industry professionals overall rank keeping customers satisfied (36 percent) as their top business priority, while growing the business (18 percent) and making a profit (18 percent) come in a distant second.
Sign-up for P&G Professional™ Survey Reveals Customer Satisfaction is Top Priority Over Company Growth and Profits investment picks
2014/9/8
Strong Indicative Alteration Confirms Priority Basement Drill Targets at Hidden Bay Canada NewsWire Trading Symbol: UEX-TSX VANCOUVER , Sept.
Sign-up for Strong Indicative Alteration Confirms Priority Basement Drill Targets at Hidden Bay investment picks
2014/9/5
Clear Channel Communications, Inc. (“CCU”) announced today that it intends to offer, subject to market and customary conditions, $750.0 million in aggregate principal amount of Priority Guarantee Notes due 2022 (the “Notes”) in a private offering that is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). The Notes will be fully and unconditionally guaranteed on a senior secured basis by CCU’s parent, Clear Channel Capital I, LLC, and all of CCU’s existing and future material wholly-owned domestic restricted subsidiaries.
Sign-up for Clear Channel Communications, Inc. Announces Proposed Private Offering of $750.0 Million of Priority Guarantee Notes due 2022 investment picks
2014/9/10
Clear Channel Communications, Inc. (“CCU”) announced today the closing of its previously announced offering of $750.0 million aggregate principal amount of its 9.0% Priority Guarantee Notes due 2022 (the “Notes”). The Notes are fully and unconditionally guaranteed on a senior secured basis by CCU’s parent, Clear Channel Capital I, LLC, and all of CCU’s existing and future material wholly-owned domestic restricted subsidiaries.
Sign-up for Clear Channel Communications, Inc. Announces Closing of Offering of 9.0% Priority Guarantee Notes Due 2022 investment picks
2014/9/5
Clear Channel Communications, Inc. (“CCU”) announced today the pricing of its previously announced offering of $750.0 million aggregate principal amount of its 9.0% Priority Guarantee Notes due 2022 (the “Notes”). The Notes will be fully and unconditionally guaranteed on a senior secured basis by CCU’s parent, Clear Channel Capital I, LLC, and all of CCU’s existing and future material wholly-owned domestic restricted subsidiaries.
Sign-up for Clear Channel Communications, Inc. Announces Pricing of Offering of 9.0% Priority Guarantee Notes due 2022 investment picks
TAMPA, Fla., June 16, 2014 (GLOBE NEWSWIRE) -- Quality Distribution, Inc. (Nasdaq:QLTY) announced today that its wholly owned subsidiaries, Quality Distribution, LLC ("QD LLC") and QD Capital Corporation ("QD Capital" and, together with QD LLC, the "Issuers"), have issued notice that they will redeem $22.5 million in aggregate principal amount of their 9.875% Second-Priority Senior Notes due 2018 (the "2018 Notes") on July 16, 2014 (the "Redemption Date"). The redemption price for the 2018 Notes will be equal to 100% of the aggregate redemption amount of $22.5 million (plus accrued but unpaid interest up to the Redemption Date) plus a 3.0% premium.
Sign-up for Quality Distribution, Inc. Announces Intention to Redeem $22.5 Million of Second-Priority Senior Notes investment picks
Macy's and Reading Is Fundamental Launch Be Book Smart Campaign June 18 to Support Children's Literacy WASHINGTON , June 18, 2014 /PRNewswire-USNewswire/ -- Despite research that indicates the importance of summer reading in preventing children from losing literacy skills, only 17 percent of parents say reading is a top summer priority, according to a new survey from Reading Is Fundamental (RIF) and Macy's.
Sign-up for New Survey: Only 17 Percent of Parents Believe Reading is Top Priority During the Summer; Kids Spend Nearly Triple the Time Playing Video Games or Watching TV investment picks
BUFFALO, N.Y. and KEYSTONE, Colo., July 29, 2014 (GLOBE NEWSWIRE) -- Synacor Inc. (Nasdaq:SYNC) , the leading provider of next-gen startpages, homescreens, award-winning TV Everywhere solutions and cloud-based Identity Management (IDM) services, across multiple devices for cable, satellite, telecom and consumer electronics companies in the U.S. and abroad, today announced it will demo at CableLabs Summer Conference its newest products, all designed with MVPDs' top priorities in mind: mobile, cloud, amazing customer experience.
Sign-up for Synacor at CableLabs Summer Conference 2014 to Demo Latest Next-Gen Products Addressing Cable Operators' Top Priorities: Mobile, Cloud, Amazing Customer Experience investment picks
2014/8/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0963505001&sourceType=1 http://www.ccnmatthews.com/logos/20080509-norandae.jpg SALABERRY-DE-VALLEYFIELD, QUEBEC --
Sign-up for Noranda Income Fund Announces a Cash Distribution for the Month of August 2014 of $0.04167 per Priority Unit investment picks
2014/6/18
Please replace the release with the following corrected version due to multiple revisions.
Sign-up for CORRECTING and REPLACING Walgreens and Arizona Priority Care Announce Collaboration for Population Health Management investment picks
Korn Ferry (NYSE:KFY), a single source of leadership and talent consulting services, today unveiled results from its 2014 Korn Ferry Marketing Pulse Survey.
Sign-up for Korn Ferry Survey: CMOs’ Top Priority Remains How to Best Engage with Customers investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Priorities
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Presentations  |  Next: Research Problems